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Abstract: Background and objective: No current nationwide consensus exists on pilonidal disease (PD) 
treatment in Switzerland and Austria. The objective of this study was to assess and compare the 
spectrum of PD treatment strategies in Switzerland and Austria. Materials and Methods: A survey 
including 196 certified institutions (Switzerland, N = 99 and Austria, N = 97) was performed. 
Treatment strategies for both chronic and acute pilonidal disease were investigated, as well as 
evolution of treatment over the last 20 years. Results: In total, 92 of 196 (47%) hospitals participated 
in the survey. Recurrence rate (20%) was similar between the two countries. In acute pilonidal 
disease, a two-stage approach with incision and drainage as the first step was preferred over a one-
stage procedure in both countries. In Austria, all patients with chronic pilonidal disease were treated 
as inpatients, whereas 28% of patients in Switzerland were treated on an outpatient basis (p = 
0.0019). Median length of hospital stay was double in Austria (four days) compared to Switzerland 
(two days; p < 0.001). Primary resection and off-midline closure (p = 0.017) and the use of tissue flaps 
(p = 0.023) were performed more commonly in Austria than in Switzerland. Minimally invasive 
techniques were performed more often in Switzerland than in Austria (52% vs. 4%, p < 0.001). 
Overall, wide excision with secondary wound healing or midline closures declined over the last 20 
years. Conclusion: Treatment strategies for chronic PD differ between Austria and Switzerland with 
more and longer inpatient care in Austria, increasingly minimally invasive approaches in 
Switzerland, and outdated procedures still being performed in both countries. Overall, 
heterogeneity of practice dominates in both countries. 
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1. Introduction 
Pilonidal disease (PD) is a common disease with an estimated incidence of 26 per 100,000 
individuals, mostly affecting young men [1]. It was initially hypothesized that PD arises from 
ingrowing hair forming sinus tracts [2]. More recently, inter-gluteal hairs were found to be stiffer in 
patients with PD, possibly enabling hair injections into healthy skin and sinus generation [3]. PD may 
present as a chronic discharging sinus, an acute abscess formation, or as asymptomatic pits [4,5]. 
Several different treatment options have been proposed over the last several decades for chronic 
disease including: limited or wide excision [6,7] with consecutive direct closure, and secondary 
wound healing or tissue flaps [8,9]. Other treatments include injection of fibrin glue [10,11] or phenol 
[4,12] into sinus tracts. Video-assisted ablation of pilonidal sinus (VAAPS) was described in 2014 
where sinus cavity ablation and cleaning are minimally invasively performed under videoscopic 
guidance [13–15]. Acute abscess formation is typically treated by incision and drainage. Whereas 
some authors routinely perform secondary pilonidal excision after abscess drainage, others think that 
abscess incision may definitely cure the disease [4,5]. Despite the high incidence of pilonidal disease, 
consensus on optimal treatment is lacking within the literature [4,5]. 
The objective of this study was to assess the treatment strategies of pilonidal disease in two 
European countries and whether a treatment consensus can be identified in daily practice. 
2. Materials and Methods 
2.1. Participants 
A total of 196 hospitals treating patients suffering from PD were identified: 99 institutions in 
Switzerland according to the registry of certified training institutions for Surgery of the Swiss 
Institute for Postgraduate and Further Education in Medicine (SIWF; https://www.fmh.ch/bildung-
siwf.html) were identified; and 97 institutions were identified in Austria according to the list of 
hospitals provided by the Austrian Federal Ministry of Health and Women (Federal Ministry of 
Health and Women, https://www.sozialministerium.at/site/). 
2.2. Questionnaire 
A multicenter binational survey in Switzerland and Austria was conducted using an online 
platform (soscisurvey.de, SoSci Survey GmbH, Munich, Germany). The survey was sent to and 
answered by the head of the surgical department (or their representative) of the queried hospital. 
Questions covered general information about the hospital, the treatment unit for PD, treatment 
strategies for acute and chronic pilonidal disease, and the evolution of this treatment (temporal 
trends) (see supplementary Material). The survey was conducted between June and July 2016. 
Hospitals were contacted via email and a link to the survey was provided. A secondary (reminder) 
email was sent to the non-responders after one month. 
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2.3. Statistics 
GraphPad Prism (www.graphpad.com) and GraphPad homepage 
(https://www.graphpad.com/quickcalcs/contingency1/), as well as SPSS version 25 (IBM corp., 
Armonk, NY, USA) were used for data analysis. 
Continuous variables are reported as mean and standard deviation (SD) or median and 
interquartile range and compared between the two groups using two-sample independent t-tests or 
Mann–Whitney U test (non-normal data). Normality was assessed using graphical methods (Q–Q 
plots and histograms) and the Shapiro–Wilk test. 
Categorical variables are summarized as frequencies (%) and were compared using Pearson’s 
chi-squared test or Fisher’s exact test where applicable. p-values < 0.05 (two- tailed) were considered 
statistically significant. 
Possible survey responses on treatments of chronic pilonidal disease were based on a 5-point 
Likert scale assessing the frequency of use of each treatment: 1: always; 2: often; 3: sometimes; 4: 
seldom; and 5: never, and compared between groups using a two-tailed Fisher’s exact test. p-values 
less than 0.05 were considered statistically significant. 
3. Results 
3.1. Response Rate, Size, and Case Load of Participating Hospitals 
In total, 92 of 196 (47%) hospitals participated in the survey. Of this cohort, 40 hospitals (43%) 
were located in Austria and 52 (57%) in Switzerland. Participating hospitals had a median number 
of 186 beds (ranging from 30 to 1500 beds) with significantly fewer (median 130) beds in Switzerland 
compared to Austria (median = 263, p = 0.001). In total, a median number of 40 surgeries per year 
were executed for pilonidal disease in the included hospitals (ranging from 5 to 500 surgeries per 
year). Median number of surgeries in Switzerland (n = 30) was not statistically significantly different 
from Austria (n = 50; p = 0.056). The mean percentage of relapse surgeries for PD (i.e., number of 
relapse surgeries divided by primary surgeries) was 18.2 (SD 9.1) in Austria and 19.7 (SD 8.8) in 
Switzerland, which was comparable between the two countries. The overall percentage of relapse 
surgeries was 19% (SD 8.9; Table 1). 
Table 1. Hospital number, size, and surgical volume. 
 
Switzerland 
N = 52 
Austria 
N = 40 
All 
N =92 
p-Value 
Number of hospital beds (median, IQR) 130 (95–300) 263 (170–500) 186 (108–350) 0.001 
Number of primary PD surgeries/year (median, IQR)) 30 (20–50) 50 (30–70) 40 (25–60) 0.056 
Number of relapse surgeries/year (median, IQR)) 6 (3–10) 6 (5–10) 6 (5–10) 0.536 
Percentage of surgeries for recurrent PD/year (mean, 
SD) 
19.7 (8.8) 18.2 (9.1) 19 (8.9) 0.500 
IQR = interquartile range, PD = pilonidal disease, SD = standard deviation. 
3.2. Treatment of Chronic Pilonidal Disease 
Wide excision with secondary wound healing as primary treatment for chronic PD was seldomly 
or never performed in 45% and 32% of hospitals in Switzerland and Austria, respectively, whereas 
36% (Switzerland) and 40% (Austria) of hospitals always or often let the wound heal by secondary 
intention. Primary excision with midline closure was performed even less frequently in both 
countries: 69% in Switzerland and 55% in Austria seldom or never closed the wound in the midline 
after excision. Primary off-midline closure tended to be less frequently performed in Switzerland 
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versus in Austria. Only 5% of hospitals always or often used tissue flaps in Switzerland, whereas 
tissue flaps were always or often used in Austria in 27% of patients (p = 0.023). The Limberg flap was 
by far the most common type of flap performed both in Switzerland (67%) and in Austria (77%)., 
Minimally invasive techniques seemed to be more commonly applied in Switzerland than in Austria. 
When queried about technical details with regard to minimal invasive procedures, limited 
fistulectomy was most frequently (82%) endorsed in Switzerland, whereas pit-picking was the most 
frequently (75%) performed procedure in Austria. 
None of the included hospitals in Switzerland or Austria used alternative treatment methods 
such as instillation of Fibrin or Phenol into sinus tracts. Only 2.1% of Swiss and 6.7% of Austrian 
hospitals used laser coagulation of the sinus tracts as alternative treatment methods. Of Swiss and 
Austrian hospitals, 19% and 33.3% applied negative pressure therapy to promote wound healing 
after excision of chronic PD, respectively. Most participants (90.2% in Switzerland and 85.7% in 
Austria) marked the sinus tracts (using methylene or toluidine blue), whereas less than half (34.1% 
in Switzerland and 42.9% in Austria) used perioperative antibiotics. The median length of hospital 
stay was significantly shorter (two days) in Switzerland compared to Austria (four days; p < 0.001). 
Only 28% of hospitals treated PD as outpatients in Switzerland, whereas all included hospitals 
treated PD as inpatients in Austria (p = 0.0019; Table 2). 
Table 2. Treatment of chronic pilonidal disease. 
  Switzerland Austria All p-Value 
Secondary wound healing, n (%) 47 (100%) 28 (100%) 75 (100%)  
 Always 3 (6%) 3 (11%) 6 (8%) 0.665 
 Often 14 (30%) 8 (29%) 22 (29%) 1 
 Sometimes 9 (19%) 8 (29%) 17 (23%) 0.399 
 Seldom 14 (30%) 7 (25%) 21 (28%) 0.792 
 Never 7 (15%) 2 (7%) 9 (12%) 0.47 
Midline wound closure, n (%) 45 (100%) 29 (100%) 74 (100%)  
 Always 0 (0%) 2 (7%) 2 (3%) 0.15 
 Often 1 (2%) 2 (7%) 3 (4%) 0.557 
 Sometimes 13 (29%) 9 (31%) 22 (30%) 1 
 Seldom 12 (27%) 4 (14%) 16 (22%) 0.252 
 Never 19 (42%) 12 (41%) 31 (42%) 1 
Off-midline wound closure, n (%) 45 (100%) 28 (100%) 73 (100%)  
 Always 0 (0%) 3 (11%) 3 (4%) 0.053 
 Often 5 (11%) 7 (25%) 12 (16%) 0.193 
 Sometimes 6 (13%) 7 (25%) 13 (18%) 0.225 
 Seldom 17 (38%) 3 (11%) 20 (27%) 0.015 
 Never 17 (38%) 8 (29%) 25 (34%) 0.458 
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Wound closure with tissue flaps, n (%) 40 (100%) 26 (100%) 66 (100%)  
 Always 0 (0%) 5 (19%) 5 (8%) 0.0074 
 Often 2 (5%) 2 (8%) 4 (6%) 0.644 
 Sometimes 12 (30%) 5 (19%) 17 (26%) 0.397 
 Seldom 16 (40%) 8 (31%) 24 (36%) 0.601 
 Never 10 (25%) 6 (23%) 16 (24%) 1 
Type of flap, n (%)     
 Limberg flap 24 (66.7) 17 (77.3) 41 (70.7) 0.554 
 Modified Limberg flap 8 (22.2) 2 (9.1) 10 (17.2) 0.29 
 Other 4 (11.1) 3 (13.6) 7 (12.1) 1 
Minimal invasive treatment, n (%) 42 (100%) 13 (100%) 55 (100%)  
 Always 9 (21%) 0 (0%) 9 (16%) 0.096 
 Often 13 (31%) 1 (8%) 14 (25%) 0.147 
 Sometimes 9 (21%) 3 (23%) 12 (22%) 1 
 Seldom 6 (14%) 8 (62%) 14 (25%) 0.0017 
 Never 5 (12%) 1 (8%) 6 (11%) 1 
Type of minimal invasive treatment, n (%) 31 (81.6)    
 Fistulectomy 4 (10.5) 2 (16.7) 33 (66) <0.001 
 Pit picking 3 (7.9) 9 (75) 13 (26) <0.001 
 Other   1 (8.3) 4 (8) 1 
Instillation of Fibrin or Phenol into sinus tracts, n (%) 0 0 0 - 
Laser instillation of sinus tracts, n (%) 1 (2.1) 2 (6.7) 3 (3.9) 0.557 
Negative pressure therapy, n (%) 9 (19) 10 (33.3) 19 (24.7) 0.183 
Marking of sinus tracts (methylene or toluidine blue), n (%) 37 (90.2) 24 (85.7) 61 (88.4) 0.706 
Use of perioperative antibiotics, n (%) 14 (34.1) 12 (42.9) 26 (37.7) 0.613 
Length of hospital stay, median (IQR), (days) 2 (1–3) 4 (2–4) 3 (2–4) < 0.001 
Percentage of same-day surgeries 28% 0% 16% 0.0019 
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3.3. Operative Technique for Acute Pilonidal Disease 
Only a minority of participating hospitals (13.3% in Switzerland and 23.3% in Austria) used 
complete excision with an intended one-stage procedure to treat acute PD. Similarly, only 20% of 
participants (20% in both Switzerland and Austria) used incision and drainage without consecutive 
secondary excision to treat acute PD. Most participating hospitals (64% in Switzerland and 67% in 
Austria) applied a two-stage procedure (with incision and drainage of the acute abscess formation 
and secondary excision) for acute PD. The exact procedure during secondary excision (i.e., excision 
and primary closure vs. excision and healing by secondary intention vs. excision and flap 
reconstruction) was not assessed in the present survey (Table 3). 
Table 3. Treatment of acute pilonidal disease (PD). 
 Switzerland Austria All p-Value 
Primary complete excision of acute PD, n (%) 6 (13.3) 7 (23.3) 13 (17.3) 0.353 
Incision only for acute PD, n (%) 9 (20) 6 (20) 15 (20) 1.000 
Two-stage procedure for acute PD, n (%) 29 (64.4) 20 (66.7) 49 (65.3) 1.000 
3.4. Chronic PD Treatment 20 Years Ago vs. Now 
Currently, wide excision with secondary wound healing is performed less frequently both in 
Switzerland and in Austria than 20 years ago. Similarly, primary midline closures have declined over 
time in Switzerland and Austria. For off-midline closures, the trend runs in the opposite direction 
with Swiss surgeons performing less off-midline closures in favor of minimally invasive techniques, 
and Austrian surgeons performing off-midline closures more frequently than two decades ago. 
Lastly, use of tissue flaps has increased over time, with now almost every second Swiss surgeon and 
more than half the Austrian surgeons taking advantage of tissue flaps (Table 4). 
Table 4. Chronic pilonidal disease treatment 20 years ago versus now. 
  Switzerland Austria All p-Value 
Wide excision with secondary wound healing, n (%)     
- more often 3 (8) 2 (8) 5 (7) 1 
- same frequency 11 (27) 6 (23) 17 (26) 0.778 
- less common 26 (65) 18 (69) 44 (67) 1 
Midline wound closures, n (%)     
- more often 7 (18) 6 (24) 13 (20) 0.541 
- same frequency 8 (20) 4 (16) 12 (18) 0.751 
- less common 25 (62) 15 (60) 40 (62) 1 
Off-midline wound closures, n (%)      
- more often 10 (26) 14 (52) 24 (36) 0.039 
- same frequency 5 (13) 2 (7) 7 (11) 0.691 
- less common 24 (61) 11 (41) 35 (53) 0.133 
Flap repair, n (%)     
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- more often 19 (48) 15 (58) 34 (52) 0.455 
- same frequency 7 (17) 5 (19) 12 (18) 1 
- less common 14 (35) 6 (23) 20 (30) 0.291 
4. Discussion 
In the present study, a total of 92 hospitals representative of Swiss (n = 52) and Austrian (n = 40) 
practice reported their treatment strategies for acute and chronic PD. The median number of primary 
procedures (40 yearly) per hospital and rate of surgery for recurrent PD (about 20%) were similar 
between the two countries and reflected the real-life data outside of dedicated expert centers. In acute 
PD, there was consensus among Swiss and Austrian surgeons in performing a two-step approach 
with incision as a first step, in accordance with current evidence [16,17]. 
In chronic PD, surgeons in both countries generally performed wide excision with secondary 
wound healing in about one-third of cases. Both Swiss and Austrian surgeons preferred off-midline 
closure techniques to midline sutured closures. This is in accordance with the current evidence that 
off-midline closure techniques are associated with lower complications rates, healing time, and 
recurrence rates [18–21]. Notably, in Austria, primary resection and off-midline closure and the use 
of tissue flaps were performed significantly more frequently compared to Switzerland. In both 
countries, the Limberg flap was the preferred technique if flap treatment was required. In contrast to 
Austria, Swiss surgeons largely preferred conducting minimally invasive approaches in chronic PD, 
with fistulectomy being the most frequently performed technique in Switzerland and pit picking 
being the preferred technique in Austria. Compared with PD treatment in former times, surgeons in 
contemporary practice less frequently performed wide excision with secondary wound healing and 
midline closures. 
The present survey was answered by the head of the surgical department or their representative. 
Although the views of the departmental head may not always be followed by all staff surgeons and 
residents, compliance with departmental treatment policy is generally very high in the Swiss and 
Austrian health care systems. Most continental European hospitals comply with a uniform treatment 
doctrine, as opposed to the U.K. and North American consultant-based health care system, where 
heterogeneity of practice within a given institution is common. Similarly, Swiss and Austrian 
hospitals are obliged to yearly report the number of procedures performed for a given disease, 
providing accurate estimates of caseload. 
Regarding the overall response rate, about every second hospital provided its response. 
Representativeness of the results can hence be assumed. The observed response rate of 47% is higher 
than the typical response rate of 30–40%, which is expected for an external survey well targeted to its 
population of interest [22–24]. A survey sent to >60,000 Canadian physicians showed an overall 
response rate of 32% [25], whereas a meta-analysis summarizing the response rates to surveys among 
surgery residents in the U.S. reported an average response rate of 43% among nationwide surveys 
[26]. Response rates to surveys differ among disciplines, being even lower than 30% among general 
surgeons, possibly reflecting their busy daily schedule [22,27]. Nevertheless, the present survey’s 
results may be confounded by an unequal nonresponse among participants, leading to sampling bias. 
For example, more experienced surgeons in the field of PD might have a lower nonresponse rate and 
may be more prone to try innovative therapeutic approaches (e.g., limited fistulectomy or laser 
assisted procedure). 
Both Switzerland and Austria are located in the center of Europe and are dominated 
geographically by the Alps, share a common culture, and have a similar life expectancy (Austria 81.3 
years, Switzerland 83.0 years). Although both countries have a nearly identical population size (AT 
8.7 million vs. CH 8.5 million), Switzerland is much more densely populated than Austria (216 vs. 
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106 per km2), with 87% of the Swiss population living in urban centers compared to only 58% in 
Austria. The Austrian health system provides universal coverage, with low out-of-pocket spending. 
In contrast, in Switzerland out-of-pocket payments constitute 5.3% of final household consumption, 
which is among the highest share in the Organization for Economic Co-operation and Development 
(OECD). 
The total number of hospitals in Switzerland and Austria are comparable (283 vs. 273). 
Nonetheless, Austria has a significantly higher number of hospital beds than Switzerland (7.55 vs. 
4.58 per 1000), whereas outpatient consultations and ambulatory surgery are below OECD averages 
in Austria. The Austrian health system’s focus on inpatient care is also reflected in the number of 
surgeons per patient, which is significantly higher in Austria than in Switzerland (1 vs. 0.8 per 1000). 
In this context, PD was uniformly approached as an inpatient treatment in Austria and that 
length of hospital stay was double compared to Switzerland, where about one-third of PD patient are 
treated in ambulatory care. Minimal invasive treatment of chronic PD can be performed in local 
anesthesia and is generally performed on an outpatient basis. As outpatient treatment of PD is almost 
never performed in Austria, it is not surprising that these techniques were less frequently performed. 
Minimally invasive surgery in PD is less invasive and an earlier return to work is possible than with 
excisional techniques [28]. Minimally invasive surgery has a higher recurrence rate compared to 
excisional surgery [17,19]. Thus, it is primarily recommended for small lesions that have not been 
surgically treated before [17]. As there are limited data comparing the different minimally invasive 
techniques in chronic PD, the choice is left to the surgeons’ preference. The observed preference for 
fistulectomy in Switzerland may be associated with it first being described by Swiss surgeons [7]. 
Another minimally invasive technique using video-assisted ablation of PD was described in 2014 in 
Italy showing promising results [13–15]. Nevertheless, VAAPS was not assessed in the present 
survey. 
5. Conclusions 
This nationwide survey showed that PD caseload and recurrence rates are comparable between 
Switzerland and Austria. Outdated procedures, such as midline closures and open wound treatments 
after primary resection, are still performed by some surgeons in both countries, but less commonly 
than 20 years ago. As there is no consensus in the current published literature on the choice of therapy 
for chronic PD; the preferred technique likely depends on the surrounding socio-economic and 
demographic conditions of a treatment center. As outpatient treatment is trending in Switzerland, 
minimally invasive techniques are more often performed. In Austria, more radical surgery with 
excision and off-midline closure or flap-treatment, which generally requires inpatient treatment and 
may have a lower recurrence rate, are preferred over minimal invasive techniques. The percentages 
of surgery for recurrent PD were similar between Austria and Switzerland. Overall, a dominant or 
consensus treatment strategy for PD remains elusive, which is reflected in the heterogeneity of 
treatment modalities reported in the present study. 
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